AI-driven platforms like OpenEvidence could significantly transform healthcare by enhancing diagnostic accuracy and treatment efficiency.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The Miami-based medical startup closed a $250 million round that led to a $15 billion valuation. Its rapid growth also raises questions about the weight of pharmaceutical advertising in a tool used to support clinical decisions.
Almost two thirds of doctors in the United States are using a search mechanism with AI (artificial intelligence) to make decisions about patients. The phenomenon led a little known technology startup to an assessment of US$ 15 billion (R$ 75.42 billion) and provoked a debate about the future of medical care. Read more (10/21/2026